NCT01213199

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars. A Pilot Study.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

Conditions

• Acne Scars

Interventions

Type	Name	Description
DRUG	Adapalene	Adapalene Gel 0.3%

Timeline

• Start date: 2011-03-01
• Primary completion: 2012-04-01
• Completion: 2012-09-01
• First posted: 2010-10-01
• Last updated: 2021-02-18
• Results posted: 2015-03-23

Locations

1 site across 1 country: United States